123 completed, 27 terminated, 17 recruiting, 15 active not recruiting. 77 Phase 2, 56 Phase 1, 34 Phase 3, 28 Phase 4, 27 Not applicable.
Follow Diphenhydramine: new trials by email Literature Review of Diphenhydramine trials Research Report on Diphenhydramine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer Dexamethasone, Famotidine, Diphenhydramine - Triple Negative Breast Cancer, Triple Negative Breast Cancer (TNBC) | Phase 2 | Not yet recruiting | Washington University School of Medicine | 17 | 2026-11-30 | 2026-11-03 |
| A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001) MK-6255, CD8 PET Tracer, Acetaminophen - Ovarian Neoplasms, Endometrial Neoplasms | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 80 | 2026-11-13 | 2026-11-16 |
| Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project Cetirizine, Diphenhydramine - Multiple Sclerosis | Phase 3 | Not yet recruiting | University of Miami | 60 | 2026-11-01 | 2026-10-02 |
| A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) MK-1045, Acetaminophen (or similar antipyretic), Diphenhydramine (or similar antihistamine) - Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma | Phase 2 | Recruiting | Merck Sharp & Dohme LLC | 60 | 2026-10-14 | 2026-11-13 |
| Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer Toripalimab (240mg day1, Q3W*3cycle), Diphenhydramine, Platinum-based chemotherapy - NSCLC | Phase 2 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 120 | 2026-06-30 | 2026-06-12 |
| Diphenhydramine as an Adjunct to Moderate Sedation for Procedural First Trimester Abortions Diphenhydramine, Placebo - Pain, Abortion | Phase 4 | Recruiting | University of Rochester | 98 | 2026-06-29 | 2026-08-21 |
| A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005) MK-1045, Blinatumomab, Acetaminophen - B-cell Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 340 | 2026-05-18 | 2026-11-10 |
| A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia Sleep Hygiene Education, Melatonin IR, 3 mg, Melatonin IR, 5 mg - Insomnia, Insomnia Disorder | Phase 4 | Recruiting | University of Pennsylvania | 1200 | 2026-05-01 | 2026-09-16 |
| Histamines and Central Hemodynamics Diphenhydramine hydrochloride, Placebo, Exercise Bout - Histamine, Exercise | Not applicable | Recruiting | University of British Columbia | 20 | 2025-12-01 | 2025-12-23 |
| Lidocaine Versus Diphenhydramine to Achieve Local Anesthesia for Laceration Repairs Lidocaine, Diphenhydramine - Laceration of Skin | Phase 3 | Recruiting | Florida Atlantic University | 100 | 2025-09-03 | 2026-01-07 |
| The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion, 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion, 25 mg Diphenhydramine (5 min) + Normal Saline - Alcohol Use Disorder (AUD), Alcohol-Related Disorders | Phase 1 | Recruiting | Yale University | 63 | 2025-08-04 | 2026-09-10 |
| Anticholinergics for Cervical Edema in Labor Treatment with Diphenhydramine, Usual Care - Labor Dystocia | Phase 2 / Phase 3 | Recruiting | The University of Texas Health Science Center, Houston | 200 | 2025-03-25 | 2026-05-06 |
| A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma Isatuximab SC-OBDS, Montelukast, Dexamethasone - Plasma Cell Myeloma Refractory | Phase 2 | Active not recruiting | Sanofi | 64 | 2025-03-17 | 2026-10-26 |
| Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients PBM Therapy, Maalox plus Benadryl - Aphthous Ulcer | Phase 4 | Recruiting | The University of Texas Health Science Center, Houston | 30 | 2025-03-10 | 2025-03-25 |
| Topical Tripelennamine 1% Cream Versus Diphenhydramine 1% Cream for the Relief of Histamine-Induced Itching: A Proof Concept Study in Healthy Adults. Tripelennamine, Diphenhydramine, Vehicle Control Cream Base - Healthy | Early Phase 1 | Completed | Palm Beach Atlantic University | 37 | 2025-02-24 | 2026-08-21 |
| Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis Anti-itching and repairing treatment. Emollient., Emollient cream - Atopic Dermatitis, Eczema | Not applicable | Completed | NAOS Les Laboratoires | 64 | 2024-12-09 | 2026-10-13 |
| Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist(Diphenhydramine)in Advanced and Metastatic Non-Small Cell Lung Cancer Diphenhydramine, Tislelizumab, Pemetrexed - Advanced and Metastatic NSCLC | Phase 3 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 430 | 2024-12-01 | 2024-12-16 |
| Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria Cetirizine Hydrochloride Injection, Diphenhydramine Hydrochloride Injection - Acute Urticaria | Phase 3 | Recruiting | Shandong New Time Pharmaceutical Co., LTD | 284 | 2024-04-22 | 2025-02-11 |
| Diphenhydramine in Catheter Related Bladder Discomfort DiphenhydrAMINE 50 Mg/mL Injectable Solution, Saline - Catheter Complications | Not applicable | Unknown | Cairo University | 104 | 2024-04-01 | 2024-04-03 |
| Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma Iberdomide, Carfilzomib, Daratumumab - Refractory Multiple Myeloma, Relapsed Multiple Myeloma | Phase 2 | Recruiting | Benjamin T Diamond, MD | 30 | 2024-02-20 | 2026-03-11 |
Showing 20 of 207. Sign in to see all of them.
Migraine Disorders (11) · Multiple Myeloma (10) · Pain (8) · Headache (7) · Lymphoma, Non-Hodgkin (7) · Nausea (6) · Neoplasms (6) · Breast Neoplasms (5) · Burkitt Lymphoma (5) · Lymphoma (5) · Vomiting (5) · Hematologic Neoplasms (4) · Hodgkin Disease (4) · Leukemia (4) · Lupus Erythematosus, Systemic (4)
National Cancer Institute (NCI) (17) · M.D. Anderson Cancer Center (9) · National Institute of Allergy and Infectious Diseases (NIAID) (9) · Sanofi (9) · Hoffmann-La Roche (7) · Montefiore Medical Center (7) · Genentech, Inc. (5) · Stanford University (5) · Merck Sharp & Dohme LLC (4) · Arrowhead Pharmaceuticals (3) · Johnson & Johnson Consumer and Personal Products Worldwide (3) · Bayer (2) · Charleston Laboratories, Inc (2) · Dr. Reddy's Laboratories Limited (2) · Eli Lilly and Company (2)
United States (156) · Canada (18) · Spain (14) · China (11) · France (11) · Italy (11) · Brazil (9) · Germany (9) · Poland (9) · United Kingdom (8) · Australia (7) · Japan (7) · Israel (6) · Greece (5) · Russia (5)
Alice P Chen, M.D. (2) · Janine North, B.S. (2) · Jeffrey Bluestone, PhD (2) · Melissa Israel, BS (2) · N. Netaji, MD (2) · Paul Brunetta, M.D. (2) · Qizhi Tang, PhD (2)
PMID 37678236, PMID 33693991, PMID 35622074, PMID 10662747, PMID 11535479, PMID 11904109, PMID 11927799, PMID 12119802, PMID 12598264, PMID 12764341, PMID 12832331, PMID 14633551, PMID 15066944, PMID 15107371, PMID 15710782, PMID 15738343, PMID 15834219, PMID 16804691, PMID 17157685, PMID 17515447, PMID 17515448, PMID 17560739, PMID 18006188, PMID 18387702, PMID 18534808, PMID 18770076, PMID 18958996, PMID 19320625, PMID 20039413, PMID 20045576, PMID 20179242, PMID 20837887, PMID 21464363, PMID 21676165, PMID 21873334, PMID 21880111, PMID 22231479, PMID 22311903, PMID 22563089, PMID 23385150, PMID 23446076, PMID 23567060, PMID 23607840, PMID 23936605, PMID 24030379, PMID 24094754, PMID 24127709, PMID 24180163, PMID 24462034, PMID 24465046
2023 (9), 2019 (4), 2025 (2), 2008 (1), 2014 (1), 2015 (1), 2016 (1), K24DA023186 (1), P01CA049605 (1), P30CA033572 (1), P50HD109861 (1), R01AA013746 (1), R01AT005819 (1), R21AA030649 (1), R34AI095135 (1)